{
  "ptid_time": "099_S_0880_2006-10-05",
  "img_path": "/data/qiuhui/data/adni/images/099_S_0880/2006-10-05/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 97,388 mm³, 107.1% above the reference mean. With a Z-score of 3.11 (99.9th percentile), this represents profound enlargement; whole brain volume measures 869,507 mm³, 15.5% below the reference mean. With a Z-score of -2.03 (2.1th percentile), this represents significant atrophy. ",
  "text_data": "Age is 84.2 years. Gender is Male. Education: 13 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Endocrine-Metabolic; Gastrointestinal; Smoking; Major Surgical Procedures. MMSE: 25.0. Logical Memory: 2.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 1243.00 pg/mL (normal ); Total tau: 175.10 pg/mL (normal ); Phosphorylated tau: 15.43 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant brain atrophy (whole brain volume 15.5% below reference mean, Z-score -2.03) and profound ventricular enlargement (107.1% above reference mean, Z-score 3.11), which are structural markers of neurodegeneration. Despite normal CSF biomarkers (Aβ, T-tau, P-tau) and an MMSE score of 25 (borderline normal), the degree of atrophy suggests cognitive impairment beyond normal aging.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely non-amnestic or non-AD subtype given normal biomarkers).  \n**Confidence:** **Medium** (high confidence in neurodegeneration, but MCI diagnosis is less certain due to near-normal MMSE and lack of detailed cognitive domain testing).  \n\n*Note: Vascular or other non-AD pathology (e.g., hippocampal-sparing tauopathy) should be considered given the discordance between structural changes and biomarker profile.*",
  "timestamp": "2025-07-26T10:59:02.152070"
}